Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01238250
Other study ID # 2023-1257
Secondary ID Simons Searchlig
Status Recruiting
Phase
First received
Last updated
Start date October 2010
Est. completion date October 2050

Study information

Verified date January 2024
Source Simons Searchlight
Contact Simons Searchlight Study Coordinator
Phone 855-329-5638
Email coordinator@SimonsSearchlight.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders and may be associated with autism. Simons Searchlight collects medical, behavioral, learning, and developmental information from people who have these rare genetic changes. The goal of this study is to improve the clinical care and treatment for these people. Simons Searchlight partners with families to collect data and distribute it to qualified researchers.


Description:

Simons Searchlight has expanded over the last several years to include additional gene changes and participation through remote formats, either online or by phone. This allows English and Spanish-speaking families from across the world to participate at times that are convenient to their schedule. Participants can donate blood, saliva, or both. These samples are then linked to medical, behavioral, learning, and developmental data in order to understand the effects of specific gene changes. Information provided by participants will be stripped of any personal identifying information and made available to qualified scientists around the world. The Simons Foundation, a New York-based private foundation, is committed to finding science-based solutions and working towards the development of targeted treatments to improve the lives of people who have genetic and developmental differences.


Recruitment information / eligibility

Status Recruiting
Enrollment 100000
Est. completion date October 2050
Est. primary completion date October 2050
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Subjects of any age with a genetic condition on our eligible list along with their biological family members. Current list can be found at: https://www.simonssearchlight.org/research/what-we-study/ - Must be fluent in English or a supported language. Current supported languages are Spanish, French, and Dutch, with more to come. - Able to register and participate through our online platform, which can be accessed through any device able to connect to the internet. - Able and willing to provide consent. Exclusion Criteria: -Some genetic changes that we study have regions or variants that are not eligible for our research. This is determined during our laboratory review that is completed by trained and certified genetic counselors. These specific ineligible regions or variants can change frequently.

Study Design


Related Conditions & MeSH terms

  • 15Q13.3 Deletion Syndrome
  • 15q15 Deletions
  • 16P11.2 Deletion Syndrome
  • 16p11.2 Duplications
  • 16p11.2 Triplications
  • 16P12.2 Microdeletion
  • 16P13.11 Microdeletion Syndrome (Disorder)
  • 17Q12 Duplication Syndrome
  • 17Q12 Microdeletion Syndrome (Disorder)
  • 17q21.3 Duplications
  • 17Q21.31 Deletion Syndrome
  • 1Q21.1 Deletion
  • 1Q21.1 Microduplication Syndrome (Disorder)
  • 2p16.3 Deletions
  • 2Q37 Deletion Syndrome
  • 5q35 Deletions
  • 5q35 Duplications
  • 7q11.23 Duplications
  • 9q34 Duplications
  • ACTB
  • ACTL6B
  • ADNP
  • ADSL
  • AFF2
  • AHDC1
  • ALDH5A1
  • ANK2
  • ANK3
  • ANKRD11
  • ARHGEF9
  • ARID1B
  • ARX
  • ASH1L
  • ATRX Gene Mutation
  • AUTS2 Syndrome
  • BCKDK
  • BCL11A
  • Brain Diseases
  • BRSK2
  • CACNA1C
  • CAPRIN1
  • CASK
  • CASZ1
  • CHAMP1
  • CHD2
  • CHD3
  • CHD8
  • CIC
  • CNOT3
  • CREBBP Gene Mutation
  • Cri-du-Chat Syndrome
  • CSDE1
  • CSNK2A1
  • CTBP1
  • CTCF
  • CTNNB1 Gene Mutation
  • CUL3
  • DDX3X
  • DEAF1
  • DHCR7
  • DLG4
  • DNMT3A
  • DSCAM
  • DYRK1A
  • EBF3
  • EHMT1
  • EP300 Gene Mutation
  • FOXP1
  • GIGYF1
  • GRIN1
  • GRIN2A
  • GRIN2B
  • GRIN2D
  • HIVEP2-Related Intellectual Disability
  • HNRNPH2
  • HNRNPU
  • Intellectual Disability
  • IQSEC2-Related Syndromic Intellectual Disability
  • IRF2BPL
  • KANSL1
  • KATNAL2
  • KCNB1
  • KDM3B
  • KDM5B
  • KDM6B
  • KMT2A
  • KMT2C Gene Mutation
  • KMT2E
  • KMT5B
  • MBD5
  • MBOAT7
  • MED13L
  • MEIS2
  • MYT1L
  • NAA15
  • NBEA
  • NCKAP1
  • NEXMIF
  • NIPBL
  • NLGN2
  • NLGN3
  • NLGN4X
  • NR3C2
  • NR4A2
  • NRXN1
  • NRXN2
  • NSD1 Gene Mutation
  • PACS1
  • PHF21A
  • PHF3
  • PHIP
  • POMGNT1
  • PPP2R1A
  • PPP2R5D-Related Intellectual Disability
  • PPP3CA
  • PSMD12
  • PTCHD1
  • RELN
  • RERE
  • REST
  • RFX3
  • RIMS1
  • RORB
  • SCN1A
  • SCN2A Encephalopathy
  • SETBP1 Gene Mutation
  • SETD2 Gene Mutation
  • SETD5
  • SHANK2
  • SIN3A
  • SLC6A1
  • SLC9A6
  • SMARCA4 Gene Mutation
  • SMARCC2
  • SON
  • SOX5
  • SPAST
  • SRCAP
  • STXBP1 Encephalopathy With Epilepsy
  • SYNCRIP
  • Syndrome
  • SYNGAP1-Related Intellectual Disability
  • TANC2
  • TAOK1
  • TBR1
  • TCF20
  • TLK2
  • TRIO
  • TRIP12
  • UPF3B
  • USP9X
  • VPS13B
  • WAC
  • WDFY3
  • ZBTB20
  • ZNF292
  • ZNF462

Locations

Country Name City State
United States Boston Children's Hospital Boston Massachusetts
United States Geisinger Health System Lewisburg Pennsylvania

Sponsors (4)

Lead Sponsor Collaborator
Simons Searchlight Boston Children's Hospital, Geisinger Clinic, Simons Foundation

Country where clinical trial is conducted

United States, 

References & Publications (4)

Moreno-De-Luca A, Evans DW, Boomer KB, Hanson E, Bernier R, Goin-Kochel RP, Myers SM, Challman TD, Moreno-De-Luca D, Slane MM, Hare AE, Chung WK, Spiro JE, Faucett WA, Martin CL, Ledbetter DH. The role of parental cognitive, behavioral, and motor profiles in clinical variability in individuals with chromosome 16p11.2 deletions. JAMA Psychiatry. 2015 Feb;72(2):119-26. doi: 10.1001/jamapsychiatry.2014.2147. — View Citation

Simons Vip Consortium. Simons Variation in Individuals Project (Simons VIP): a genetics-first approach to studying autism spectrum and related neurodevelopmental disorders. Neuron. 2012 Mar 22;73(6):1063-7. doi: 10.1016/j.neuron.2012.02.014. Epub 2012 Mar 21. — View Citation

Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E, Stefansson H, Ferreira MA, Green T, Platt OS, Ruderfer DM, Walsh CA, Altshuler D, Chakravarti A, Tanzi RE, Stefansson K, Santangelo SL, Gusella JF, Sklar P, Wu BL, Daly MJ; Autism Consortium. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med. 2008 Feb 14;358(7):667-75. doi: 10.1056/NEJMoa075974. Epub 2008 Jan 9. — View Citation

Zufferey F, Sherr EH, Beckmann ND, Hanson E, Maillard AM, Hippolyte L, Mace A, Ferrari C, Kutalik Z, Andrieux J, Aylward E, Barker M, Bernier R, Bouquillon S, Conus P, Delobel B, Faucett WA, Goin-Kochel RP, Grant E, Harewood L, Hunter JV, Lebon S, Ledbetter DH, Martin CL, Mannik K, Martinet D, Mukherjee P, Ramocki MB, Spence SJ, Steinman KJ, Tjernagel J, Spiro JE, Reymond A, Beckmann JS, Chung WK, Jacquemont S; Simons VIP Consortium; 16p11.2 European Consortium. A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. J Med Genet. 2012 Oct;49(10):660-8. doi: 10.1136/jmedgenet-2012-101203. Erratum In: J Med Genet. 2014 Jul;51(7):478. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Baseline comprehensive collection of medical, behavioral, learning, and developmental information of people who have documented gene changes that are associated with features of autism and other neurodevelopmental disorders. Families with people who have specific documented gene changes that are associated with features of autism and other neurodevelopmental disorders will report detailed medical and family history information by phone. Online research surveys will be used to collect information about behavioral and learning characteristics, with the goal of improving clinical care and treatment for these people. Baseline data is collected over the course of one month, on average.
Secondary Longitudinal, or long-term, comprehensive collection of medical, behavioral, learning, and developmental information from people who have documented gene changes that are associated with features of autism and other neurodevelopmental disorders. To monitor and document the development of people who have gene changes that are related to autism and other neurodevelopmental disorders, online research surveys and updates to the family and medical history will be collected on an annual basis. Repeat data collection will occur on a regular basis and will be obtained over the course of one month, on average
See also
  Status Clinical Trial Phase
Recruiting NCT05232630 - Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes Phase 4
Not yet recruiting NCT06356233 - Phenotyping and Identification of Biological Markers in STXBP1 Encephalopathy
Not yet recruiting NCT05462054 - Natural History Study in Pediatric Patients With STXBP1 Encephalopathy With Epilepsy
Recruiting NCT05161494 - Gait in Rare Diseases